Hypercapnia in Orthostatic Hypotension

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorUniversity of Calgary

About this trial

The Autonomic (or "automatic") Nervous System (ANS) regulates internal processes, including control of heart rate and blood pressure (BP). When someone stands, and gravity tries to pull blood away from the brain, the ANS works to maintain BP and brain blood flow. Neurogenic Orthostatic Hypotension (NOH) occurs when our "fight-or-flight" part ("sympathetic") of the ANS fails. BP can drop a lot when upright, reducing blood flow and oxygen delivery to the brain, and this can cause symptoms of light-headedness, nausea, and fainting.

One solution to help counter the effects of NOH may be to increase sympathetic activity by breathing higher levels of carbon dioxide. In healthy volunteers, small increases in the amount of inhaled carbon dioxide has been shown to increase BP in the upright position, and this improves symptoms!

The objectives of the current study are to apply carbon dioxide in patients with NOH and healthy controls to: (a) evaluate the effects of breathing carbon dioxide on BP and brain blood flow, and (b) determine if a device that increases carbon dioxide while standing will work as a new therapy

Eligibility criteria

Qualifiers

Age ≥18 years

Male and Female

Non - smokers.

Able and willing to provide informed consent.

Disqualifiers

Medical therapies or medications which could interfere with testing of autonomic function

Participants with somatization or severe anxiety symptoms will be excluded

Pregnant or breast-feeding females

Inability to tolerate mask for the duration of the study

Trial design

Treatments tested in this trial

  • Sequential Gas Delivery

Treatment groups

80 Participants
are divided into 5 treatment groups

Sponsors and collaborators